202 related articles for article (PubMed ID: 21255503)
1. Tiotropium for treatment of stable COPD: a meta-analysis of clinically relevant outcomes.
Yohannes AM; Willgoss TG; Vestbo J
Respir Care; 2011 Apr; 56(4):477-87. PubMed ID: 21255503
[TBL] [Abstract][Full Text] [Related]
2. Impact of tiotropium on the course of moderate-to-very severe chronic obstructive pulmonary disease: the UPLIFT trial.
Tashkin DP
Expert Rev Respir Med; 2010 Jun; 4(3):279-89. PubMed ID: 20524910
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
Baker WL; Baker EL; Coleman CI
Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
[TBL] [Abstract][Full Text] [Related]
4. The efficacy and safety of tiotropium in Chinese patients with stable chronic obstructive pulmonary disease: a meta-analysis.
Wu Q; Li G; Lei WI; Zhou X
Respirology; 2009 Jul; 14(5):666-74. PubMed ID: 19402836
[TBL] [Abstract][Full Text] [Related]
5. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
Sobieraj DM; White CM; Coleman CI
Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
[TBL] [Abstract][Full Text] [Related]
6. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.
Lee TA; Wilke C; Joo M; Stroupe KT; Krishnan JA; Schumock GT; Pickard AS
Arch Intern Med; 2009 Aug; 169(15):1403-10. PubMed ID: 19667304
[TBL] [Abstract][Full Text] [Related]
7. Tiotropium: a new, long-acting agent for the management of COPD--a clinical review.
Crutchfield D
Director; 2004; 12(3):160, 162-4. PubMed ID: 15323298
[TBL] [Abstract][Full Text] [Related]
8. Tiotropium: a potential replacement for ipratropium in patients with COPD.
Shukla VK
Issues Emerg Health Technol; 2002 Jul; (35):1-4. PubMed ID: 12195603
[TBL] [Abstract][Full Text] [Related]
9. Tiotropium bromide: a new long-acting bronchodilator for the treatment of chronic obstructive pulmonary disease.
Koumis T; Samuel S
Clin Ther; 2005 Apr; 27(4):377-92. PubMed ID: 15922812
[TBL] [Abstract][Full Text] [Related]
10. Tiotropium: a bronchodilator for chronic obstructive pulmonary disease.
Somand H; Remington TL
Ann Pharmacother; 2005 Sep; 39(9):1467-75. PubMed ID: 16030078
[TBL] [Abstract][Full Text] [Related]
11. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.
Tashkin DP
Am J Med; 2006 Oct; 119(10 Suppl 1):63-72. PubMed ID: 16996901
[TBL] [Abstract][Full Text] [Related]
12. [Tiotropium (Spiriva) - a long-acting inhaled anticholinergic for the treatment of chronic obstructive pulmonary disease (COPD)].
Beeh KM; Welte T; Buhl R
Pneumologie; 2003 Sep; 57(9):519-25. PubMed ID: 13680472
[TBL] [Abstract][Full Text] [Related]
13. Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease.
Chen AM; Bollmeier SG; Finnegan PM
Ann Pharmacother; 2008 Dec; 42(12):1832-42. PubMed ID: 18957624
[TBL] [Abstract][Full Text] [Related]
14. Enhanced persistence with tiotropium compared with other respiratory drugs in COPD.
Breekveldt-Postma NS; Koerselman J; Erkens JA; Lammers JW; Herings RM
Respir Med; 2007 Jul; 101(7):1398-405. PubMed ID: 17368011
[TBL] [Abstract][Full Text] [Related]
15. [The verge and the abyss: tiotropium (Spiriva) in COPD].
Segel MJ; Ben-Dov I
Harefuah; 2011 Jan; 150(1):61-3, 66. PubMed ID: 21449160
[TBL] [Abstract][Full Text] [Related]
16. Additive benefits of tiotropium in COPD patients treated with long-acting beta agonists and corticosteroids.
Perng DW; Wu CC; Su KC; Lee YC; Perng RP; Tao CW
Respirology; 2006 Sep; 11(5):598-602. PubMed ID: 16916333
[TBL] [Abstract][Full Text] [Related]
17. Tiotropium for the treatment of stable chronic obstructive pulmonary disease: a systematic review with meta-analysis.
Rodrigo GJ; Nannini LJ
Pulm Pharmacol Ther; 2007; 20(5):495-502. PubMed ID: 16621638
[TBL] [Abstract][Full Text] [Related]
18. Incorporating tiotropium into a respiratory therapist-directed bronchodilator protocol for managing in-patients with COPD exacerbations decreases bronchodilator costs.
Drescher GS; Carnathan BJ; Imus S; Colice GL
Respir Care; 2008 Dec; 53(12):1678-84. PubMed ID: 19025702
[TBL] [Abstract][Full Text] [Related]
19. Survival with tiotropium compared to long-acting Beta-2-agonists in Chronic Obstructive Pulmonary Disease.
Gershon AS; Wang L; To T; Luo J; Upshur RE
COPD; 2008 Aug; 5(4):229-34. PubMed ID: 18671148
[TBL] [Abstract][Full Text] [Related]
20. Tiotropium therapy and mortality risk in COPD patients: the most severe, the most protected? Evaluation of Celli B, Decramer M, Kesten S, et al. Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009; 180(10): 948-55.
Sampablo I; Carone M; Antoniu SA
Expert Opin Pharmacother; 2010 Jun; 11(8):1439-41. PubMed ID: 20446856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]